The DOI matches its OpenAlex record; 65 of the 65 references it cites were found in a registry or an index.
C-Met Autocrine Activation Induces Development Of Malignant Melanoma And Acquisition Of The Metastatic Phenotype
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret
Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F., & Pachnis, V. (1994) · Nature · doi:10.1038/367380a0 · Cited by 1,614
Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., & Nagata, S. (1994) · Cell · doi:10.1016/0092-8674(94)90375-1 · Cited by 1,528
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Scatter factor/hepatocyte growth factor is essential for liver development
Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., & Birchmeler, C. (1995) · Nature · doi:10.1038/373699a0 · Cited by 1,394
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility
Stoker, M., Gherardi, E., Perryman, M., & Gray, J. (1987) · Nature · doi:10.1038/327239a0 · Cited by 1,314
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., & Birchmeier, C. (1995) · Nature · doi:10.1038/376768a0 · Cited by 1,284
Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor
Uehara, Y., Minowa, O., Mori, C., Shiota, K., Kuno, J., Noda, T., & Kitamura, N. (1995) · Nature · doi:10.1038/373702a0 · Cited by 1,041
Kouhara, H., Hadari, Y. R., Spivak-Kroizman, T., Schilling, J., Bar-Sagi, D., Lax, I., & Schlessinger, J. (1997) · Cell · doi:10.1016/s0092-8674(00)80252-4 · Cited by 873
Purification and characterization of a newly identified growth factor specific for epithelial cells.
Rubin, J. S., Osada, H., Finch, P. W., Taylor, W. G., Rudikoff, S., & Aaronson, S. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.3.802 · Cited by 833
Jhappan, C., Stahle, C., Harkins, R. N., Fausto, N., Smith, G. H., & Merlino, G. T. (1990) · Cell · doi:10.1016/0092-8674(90)90076-q · Cited by 710
Self-citationScatter factor induces blood vessel formation in vivo.
Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickoloff, B. J., Kinsella, J. L., Polverini, P., & Rosen, E. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1937 · Cited by 691
Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells.
Weidner, K. M., Behrens, J., Vandekerckhove, J., & Birchmeier, W. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.5.2097 · Cited by 684
The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis.
Zarnegar, R., & Michalopoulos, G. K. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.5.1177 · Cited by 569
Mechanism of met oncogene activation
Park, M., Dean, M., Cooper, C. S., Schmidt, M., O'Brien, S. J., Blair, D. G., & Vande Woude, G. F. (1986) · Cell · doi:10.1016/0092-8674(86)90564-7 · Cited by 560
A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor.
Rubin, J. S., Chan, A. M., Bottaro, D. P., Burgess, W. H., Taylor, W. G., Cech, A. C., Hirschfield, D. W., Wong, J., Miki, T., & Finch, P. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.2.415 · Cited by 493
Self-citationTakayama, H., LaRochelle, W. J., Sharp, R., Otsuka, T., Kriebel, P., Anver, M., Aaronson, S. A., & Merlino, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.701 · Cited by 440
Self-citationMohammadi, M., Dikic, I., Sorokin, A., Burgess, W. H., Jaye, M., & Schlessinger, J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.977 · Cited by 388
Rong, S., Segal, S., Anver, M., Resau, J. H., & Vande Woude, G. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4731 · Cited by 363
Self-citationTumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.
Rong, S., Bodescot, M., Blair, D., Dunn, J., Nakamura, T., Mizuno, K., Park, M., Chan, A., Aaronson, S., & Vande Woude, G. F. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5152 · Cited by 312
Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.
Renzo, M. F. D., Olivero, M., Ferro, S., Prat, M., Bongarzone, I., Pilotti, S., Belfiore, A., Costantino, A., Vigneri, R., & Pierotti, M. A. (1992) · PubMed · Cited by 312
Jeffers, M., Rong, S., & Vande Woude, G. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1115 · Cited by 307
Brinkmann, V, Foroutan, H., Sachs, M., Weidner, K. M., & Birchmeier, W. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.6.1573 · Cited by 296
Hepatocyte growth factor/scatter factor—Met signaling in tumorigenicity and invasion/metastasis
Jeffers, M., Rong, S., & Vande Woude, G. F. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00204976 · Cited by 288
Wang, Y., & Becker, D. (1997) · Nature Medicine · doi:10.1038/nm0897-887 · Cited by 284
Ferracini, R., Renzo, M. F. D., Scotlandi, K., Baldini, N., Olivero, M., Lollini, P., Cremona, O., Campanacci, M., & Comoglio, P. M. (1995) · PubMed · Cited by 280
Becker, D., Meier, C. B., & Herlyn, M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08543.x · Cited by 263
bFGF is the putative natural growth factor for human melanocytes
Halaban, R., Ghosh, S., & Baird, A. (1987) · In Vitro Cellular & Developmental Biology · doi:10.1007/bf02623492 · Cited by 262
Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
Tuck, A. B., Park, M., Sterns, E. E., Boag, A., & Elliott, B. E. (1996) · Europe PMC (PubMed Central) · Cited by 244
Royal, I., & Park, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27780 · Cited by 237
Hepatocyte growth factor--scatter factor: mitogen, motogen, and met.
Gherardi, E., & Stoker, M. G. P. (1991) · PubMed · Cited by 232
Tyrosinases from two different loci are expressed by normal and by transformed melanocytes.
Jiménez, M., Tsukamoto, K., & Hearing, V. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35295-x · Cited by 231
Hartmann, G., Naldini, L., Weidner, K. M., Sachs, M., Vigna, E., Comoglio, P. M., & Birchmeier, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.23.11574 · Cited by 220
Identification of a Competitive HGF Antagonist Encoded by an Alternative Transcript
Chan, A. M.-L., Rubin, J. S., Bottaro, D. P., Hirschfield, D. W., Chedid, M., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1720571 · Cited by 218
Self-citationPepper, M. S., Matsumoto, K., Nakamura, T., Orci, L., & Montesano, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88729-x · Cited by 216
Palmiter, R. D., Sandgren, E. P., Koeller, D. M., & Brinster, R. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.9.5266 · Cited by 209
Yokoyama, T., Silversides, D. W., Waymire, K. G., Kwon, B. S., Takeuchi, T., & Overbeek, P. A. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.24.7293 · Cited by 207
Natali, P., Nicotra, M., Di Renzo, M., Prat, M., Bigotti, A., Cavaliere, R., & Comoglio, P. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.422 · Cited by 205
Takayama, H., La Rochelle, W. J., Anver, M., Bockman, D. E., & Merlino, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5866 · Cited by 195
Self-citationKoprowski, H., Herlyn, M., Balaban, G., Parmiter, A., Ross, A., & Nowell, P. (1985) · Somatic Cell and Molecular Genetics · doi:10.1007/bf01534687 · Cited by 188
Halaban, R., Rubin, J. S., Funasaka, Y., Cobb, M. H., Boulton, T. G., Faletto, D. L., Rosen, E. M., Chan, A. M.-L., Yoko, K., & White, W. L. (1992) · PubMed · Cited by 183
Bellusci, S., Moens, G., Gaudino, G., Comoglio, P. M., Nakamura, T., Thiery, J. P., & Jouanneau, J. (1994) · PubMed · Cited by 168
Sakata, H., Takayama, H., Sharp, R., Rubin, J. S., Merlino, G. T., & LaRochelle, W. J. (1996) · PubMed · Cited by 153
Self-citationMalignant melanoma in transgenic mice.
Bradl, M., Klein–Szanto, A. J., Porter, S. D., & Mintz, B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.164 · Cited by 152
Dotto, G. P., Moellmann, G. E., Ghosh, S., Edwards, M., & Halaban, R. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.109.6.3115 · Cited by 143
The Pmel 17/silver locus protein. Characterization and investigation of its melanogenic function.
Kobayashi, T., Urabe, K., Orlow, S. J., Higashi, K., Imokawa, G., Kwon, B. S., Potterf, B., & Hearing, V. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62030-2 · Cited by 138
Lifetime risk for development of skin cancer in the U.S. population: Current estimate is now 1 in 5
Rigel, D. S., Friedman, R. J., & Kopf, A. W. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90139-5 · Cited by 134
Iwamoto, T., Takahashi, M., Ito, M. A., Hamatani, K., Ohbayashi, M., Wajjwalku, W., Isobe, K.-I., & Nakashima, I. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04878.x · Cited by 129
An alternatively processed mRNA generated from human hepatocyte growth factor gene
Miyazawa, K., Kitamura, A., Naka, D., & Kitamura, N. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb15876.x · Cited by 108
Increasing Epidermal Growth Factor Receptor Expression in Human Melanocytic Tumor Progression
de Wit, P. E. J., Moretti, S., Koenders, P. G., Weterman, M. A. J., van Muijen, G. N. P., Gianotti, B., & Ruiter, D. J. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12616793 · Cited by 102
Hendrix, M. J. C., Seftor, E. A., Seftor, R. E. B., Kirschmann, D. A., Gardner, L. M., Boldt, H. C., Meyer, M. L., Pe'er, J., & Folberg, R. (1998) · Europe PMC (PubMed Central) · Cited by 98
A point mutation in the MET oncogene abrogates metastasis without affecting transformation
Giordano, S., Bardelli, A., Zhen, Z., Ménard, S., Ponzetto, C., & Comoglio, P. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13868 · Cited by 92
Rosen, E. M., Lamszus, K., Laterra, J., Polverini, P. J., Rubin, J. S., & Goldberg, I. D. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515457.ch14 · Cited by 85
Yayon, A., Ma, Y., Safran, M., Klagsbrun, M., & Halaban, R. (1997) · Oncogene · doi:10.1038/sj.onc.1201159 · Cited by 78
Growth factors and tyrosine protein kinases in normal and malignant melanocytes
Halaban, R. (1991) · Cancer and Metastasis Reviews · doi:10.1007/bf00049410 · Cited by 59
Rahimi, N., Tremblay, E., & Elliott, B. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.40.24850 · Cited by 56
Molecular Mechanisms Controlling Human Melanoma Progression and Metastasis
Welch, D. R., & Goldberg, S. F. (2008) · Pathobiology · doi:10.1159/000164143 · Cited by 55
Detection of the c‐met proto‐oncogene product in normal skin and tumours of melanocytic origin
SAITOH, K., Takahashi, H., Sawada, N., & Parsons, P. G. (1994) · The Journal of Pathology · doi:10.1002/path.1711740308 · Cited by 53
Characterization of the Rearranged tpr-met Oncogene Breakpoint
Dean, M. C., Park, M., & Woude, G. F. V. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.921-924.1987 · Cited by 53
Interactions of Melanocytes and Melanoma Cells With the Microenvironment
Herlyn, M., & Shih, I. (1994) · Pigment Cell Research · doi:10.1111/j.1600-0749.1994.tb00025.x · Cited by 52
Hepatocyte growth factor transforms immortalized mouse liver epithelial cells.
Kanda, H., Tajima, H., Lee, G., Nomura, K., Ohtake, K., Matsumoto, K., Nakamura, T., & Kitagawa, T. (1993) · PubMed · Cited by 47
Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2
Besser, D., Bardelli, A., Didichenko, S. A., Thelen, M., Comoglio, P. M., Ponzetto, C., & Nagamine, Y. (1997) · Oncogene · doi:10.1038/sj.onc.1200879 · Cited by 46
Functional Components of Fibroblast Growth Factor (FGF) Signal Transduction in Pituitary Cells
Schweppe, R. E., Frazer‐Abel, A. A., Gutierrez‐Hartmann, A., & Bradford, A. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30852 · Cited by 43
Df, K., & Rd, L. (1996) · PubMed · Cited by 40
Pathology and Incidence of Amelanotic Melanomas of the Skin in F-344/N Rats
Yoshitomi, K., Elwell, M. R., & Boorman, G. A. (1995) · Toxicologic Pathology · doi:10.1177/019262339502300103 · Cited by 18
Signal Transduction in Normal and Malignant Melanocytes
Halaban, R. (1994) · Pigment Cell Research · doi:10.1111/j.1600-0749.1994.tb00026.x · Cited by 13
Cited by
Melanocyte biology and skin pigmentation
Lin, J. Y., & Fisher, D. E. (2007) · Nature · doi:10.1038/nature05660 · Cited by 1,379
New driver mutations in non-small-cell lung cancer
Tanoue, L. T. (2012) · Yearbook of Pulmonary Disease · doi:10.1016/j.ypdi.2012.01.036 · Cited by 831
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Comoglio, P. M., Giordano, S., & Trusolino, L. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2530 · Cited by 818
Scatter-factor and semaphorin receptors: cell signalling for invasive growth
Trusolino, L., & Comoglio, P. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc779 · Cited by 745
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Metadata
- Authors
- Otsuka, T., Takayama, H., Sharp, R., Celli, G. B., LaRochelle, W. J., Bottaro, D. P., Ellmore, N., Vieira, W., Owens, J. W., Anver, M. R., & Merlino, G. T.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 1998-01-01
- Volume
- 58
- Issue
- 22
- Pages
- 5157-67
- OpenAlex
- W1909795006
- Cited by
- 268
- References
- 65
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.